Effectiveness analysis of antimicrobial use in veterinary medicine: Balancing economic and public health considerations

Year 2025, Volume: 7 Issue: 1, 52 - 59

Aybars Oztuna

Abstract

Antimicrobial resistance (AMR) constitutes one of the significant threats to public health, and this is partly due to overuse and misuse of antimicrobials in human and veterinary medicine. The cost-effectiveness of different strategies in responsible antimicrobial use, a critical practice in veterinary sectors controlling AMR, is often unclear. This essay seeks to discuss the application of pharmacoeconomics in evaluating the economic impact and public health implications emanating from various practices in AMU in veterinary medicine. A review of the existing literature shows challenges in variability in antimicrobial use across animal species, difficulties in quantifying indirect costs, and data limitations. The essay also brings out successful studies using pharmacoeconomic models, providing insight into their potential for evidence-based decision-making. This essay focuses on the equilibrium among animal health, human health, and economic sustainability in trying to provide guidelines on future research and policy directions regarding responsible use of antimicrobials in veterinary medicine as support for veterinarians, policymakers, and researchers.

Keywords

pharmaeconomics, veterinary medicine, antimicrobial use cost-effectiveness analysis, public health, antimicrobial resistance, responsible use, economic implications, animal health, welfare

References

• Aarestrup, F. M. (2005). Veterinary drug usage and antimicrobial resistance in bacteria of animal origin. Basic & Clinical Pharmacology & Toxicology, 96(4), 271–281. https://doi.org/10.1111/j.1742-7843.2005.pto960401.x
• Adebowale, O. O., Jimoh, A. B., Adebayo, O. O., Alamu, A. A., Adeleye, A. I., Fasanmi, O. G., Olasoju, M., Olagunju, P. O., & Fasina, F. O. (2023). Evaluation of antimicrobial usage in companion animals at a Veterinary Teaching Hospital in Nigeria. Scientific Reports, 13(1), 18195. https://doi.org/10.1038/s41598-023-44485-w
• Atlanta. (2019). Antibiotic resistance threats in the United States, 2019. Centers for Disease Control and Prevention (U.S.). https://doi.org/10.15620/cdc:82532
• B., C., & Laevens, H. (2003). Antimicrobial resistance in livestock—Catry—2003—Journal of Veterinary Pharmacology and Therapeutics—Wiley Online Library. https://onlinelibrary.wiley.com/doi/abs/10.1046/j.1365-2885.2003.00463.x
• Berman, T. S., Barnett-Itzhaki, Z., Berman, T., & Marom, E. (2023). Antimicrobial resistance in food-producing animals: Towards implementing a one health based national action plan in Israel. Israel J. of Health Policy Research, (12)18. https://doi.org/10.1186/s13584-023-00562-z
• Butaye, P., Devriese, L. A., & Haesebrouck, F. (2003). Antimicrobial growth promoters used in animal feed: Effects of less well known antibiotics on gram-positive bacteria. Clinical Microbiology Reviews, 16(2), 175–188. https://doi.org/10.1128/CMR.16.2.175-188.2003
• Caneschi, A., Bardhi, A., Barbarossa, A., & Zaghini, A. (2023). The Use of Antibiotics and Antimicrobial Resistance in Veterinary Medicine, a Complex Phenomenon: A Narrative Review. Antibiotics, 12(3), 487. https://doi.org/10.3390/antibiotics12030487
• OIE Responsible 2016. February 14, 2025, from https://www.woah.org/fileadmin/Home/eng/Health_standards/tahc/current/chapitre_antibio_use.pdf Circular (Circular). (2006). [Circular].
• Critically Important Antimicrobials for Human Medicine: 5th Revision. (n.d.). Retrieved February 14, 2025, from https://www.who.int/publications/i/item/9789241512220
• de Jong, A., Thomas, V., Simjee, S., Moyaert, H., El Garch, F., Maher, K., Morrissey, I., Butty, P., Klein, U., Marion, H., Rigaut, D., & Vallé, M. (2014). Antimicrobial susceptibility monitoring of respiratory tract pathogens isolated from diseased cattle and pigs across Europe: The VetPath study. Veterinary Microbiology, 172(1–2), 202–215. https://doi.org/10.1016/j.vetmic.2014.04.008
• ECDC, EFSA and EMA Joint Scientific Opinion on a list of outcome indicators as regards surveillance of antimicrobial resistance and antimicrobial consumption in humans and food-producing animals. (2017, October 26). https://www.ecdc.europa.eu/en/publications-data/ecdc-efsa-and-ema-joint-scientific-opinion-list-outcome-indicators-regards
• Global action plan on antimicrobial resistance. (2016). https://www.who.int/publications/i/item/9789241509763
• Global Framework for Development and Stewardship to Combat Antimicrobial Resistance. (2016). https://www.who.int/groups/framework-development-stewardship-AMR
• Hall, R. M., & Collis, C. M. (1998). Antibiotic resistance in gram-negative bacteria: The role of gene cassettes and integrons. Drug Resistance Updates: Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy, 1(2), 109–119. https://doi.org/10.1016/s1368-7646(98)80026-5
• Hennessey, M., Fournié, G., Quaife, M., & Alarcon, P. (2022). Modelling multi-player strategic decisions in animal healthcare: A scoping review. Preventive Veterinary Medicine, 205, 105684.
• Hennessy, S. (2006). Use of health care databases in pharmacoepidemiology. Basic & Clinical Pharmacology & Toxicology, 98(3), 311–313. https://doi.org/10.1111/j.1742-7843.2006.pto_368.x
• John, F. P. (2013). Antimicrobial Therapy in Veterinary Medicine, Fifth Edition. https://www.researchgate.net/publication/277696103_Antimicrobial_Therapy_in_Veterinary_Medicine_Fifth_Edition
• Kovačević, Z., Mihajlović, J., Mugoša, S., Horvat, O., Tomanić, D., Kladar, N., & Samardžija, M. (2022a). Pharmacoeconomic analysis of the different therapeutic approaches in control of bovine mastitis: Phytotherapy and antimicrobial treatment. Antibiotics, 12(1), 11.
• Kovačević, Z., Mihajlović, J., Mugoša, S., Horvat, O., Tomanić, D., Kladar, N., & Samardžija, M. (2022b). Pharmacoeconomic analysis of the different therapeutic approaches in control of bovine mastitis: Phytotherapy and antimicrobial treatment. Antibiotics, 12(1), 11.
• Laxminarayan, R., Duse, A., Wattal, C., Zaidi, A. K. M., Wertheim, H. F. L., Sumpradit, N., Vlieghe, E., Hara, G. L., Gould, I. M., Goossens, H., Greko, C., So, A. D., Bigdeli, M., Tomson, G., Woodhouse, W., Ombaka, E., Peralta, A. Q., Qamar, F. N., Mir, F., & Cars, O. (2013). Antibiotic resistance-the need for global solutions. The Lancet. Infectious Diseases, 13(12), 1057–1098. https://doi.org/10.1016/S1473-3099(13)70318-9
• McEwen, S. A., & Collignon, P. J. (2018). Antimicrobial Resistance: A One Health Perspective. Microbiology Spectrum, 6(2). https://doi.org/10.1128/microbiolspec.ARBA-0009-2017
• Norris, J. M., Zhuo, A., Govendir, M., Rowbotham, S. J., Labbate, M., Degeling, C., Gilbert, G. L., Dominey-Howes, D., & Ward, M. P. (2019). Factors influencing the behaviour and perceptions of Australian veterinarians towards antibiotic use and antimicrobial resistance. PLOS ONE, 14(10), e0223534. https://doi.org/10.1371/journal.pone.0223534
• O’Neill, J. (2016). Tackling drug-resistant infections globally: Final report and recommendations.
• Phillips, I., Casewell, M., Cox, T., De Groot, B., Friis, C., Jones, R., Nightingale, C., Preston, R., & Waddell, J. (2004). Does the use of antibiotics in food animals pose a risk to human health? A critical review of published data. The Journal of Antimicrobial Chemotherapy, 53(1), 28–52.
• Rodríguez-Baño, J., Gutiérrez-Gutiérrez, B., Machuca, I., & Pascual, A. (2018). Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae. Clinical Microbiology Reviews, 31(2), e00079-17. https://doi.org/10.1128/CMR.00079-17
• Salyers, A. A., & Amábile-Cuevas, C. F. (1997). Why are antibiotic resistance genes so resistant to elimination? Antimicrobial Agents and Chemotherapy, 41(11), 2321–2325. https://doi.org/10.1128/AAC.41.11.2321
• Schwarz, S., & Chaslus-Dancla, E. (2001). Use of antimicrobials in veterinary medicine and mechanisms of resistance. Veterinary Research, 32(3–4), 201–225. https://doi.org/10.1051/vetres:2001120
• Scientific Advisory Group on Antimicrobials of the Committee for Medicinal Products for Veterinary Use. (2009). Reflection paper on the use of third and fourth generation cephalosporins in food producing animals in the European Union: Development of resistance and impact on human and animal health. Journal of Veterinary Pharmacology and Therapeutics, 32(6), 515–533. https://doi.org/10.1111/j.1365-2885.2009.01075.x
• Speksnijder, D. C., Jaarsma, A. D. C., van der Gugten, A. C., Verheij, T. J. M., & Wagenaar, J. A. (2015). Determinants associated with veterinary antimicrobial prescribing in farm animals in the Netherlands: A qualitative study. Zoonoses and Public Health, 62 Suppl 1, 39–51. https://doi.org/10.1111/zph.12168
• Suojala, L., Kaartinen, L., & Pyörälä, S. (2013). Treatment for bovine Escherichia coli mastitis—An evidence-based approach. Journal of Veterinary Pharmacology and Therapeutics, 36(6), 521–531. https://doi.org/10.1111/jvp.12057
• Tang, K. L., Caffrey, N. P., Nóbrega, D. B., Cork, S. C., Ronksley, P. E., Barkema, H. W., Polachek, A. J., Ganshorn, H., Sharma, N., Kellner, J. D., & Ghali, W. A. (2017). Restricting the use of antibiotics in food-producing animals and its associations with antibiotic resistance in food-producing animals and human beings: A systematic review and meta-analysis. The Lancet. Planetary Health, 1(8), e316–e327. https://doi.org/10.1016/S2542-5196(17)30141-9
• Tasho, R. P., & Cho, J. Y. (2016). Veterinary antibiotics in animal waste, its distribution in soil and uptake by plants: A review. The Science of the Total Environment, 563–564, 366–376. https://doi.org/10.1016/j.scitotenv.2016.04.140
• Van Boeckel, T. P., Pires, J., Silvester, R., Zhao, C., Song, J., Criscuolo, N. G., Gilbert, M., Bonhoeffer, S., & Laxminarayan, R. (2019). Global trends in antimicrobial resistance in animals in low- and middle-income countries. Science, 365(6459), eaaw1944. https://doi.org/10.1126/science.aaw1944
• Verraes, C., Van Boxstael, S., Van Meervenne, E., Van Coillie, E., Butaye, P., Catry, B., de Schaetzen, M.-A., Van Huffel, X., Imberechts, H., Dierick, K., Daube, G., Saegerman, C., De Block, J., Dewulf, J., & Herman, L. (2013a). Antimicrobial Resistance in the Food Chain: A Review. International Journal of Environmental Research and Public Health, 10(7), 2643–2669. https://doi.org/10.3390/ijerph10072643
• Verraes, C., Van Boxstael, S., Van Meervenne, E., Van Coillie, E., Butaye, P., Catry, B., de Schaetzen, M.-A., Van Huffel, X., Imberechts, H., Dierick, K., Daube, G., Saegerman, C., De Block, J., Dewulf, J., & Herman, L. (2013b). Antimicrobial Resistance in the Food Chain: A Review. International Journal of Environmental Research and Public Health, 10(7), 2643–2669. https://doi.org/10.3390/ijerph10072643
• Veterinary Antimicrobial Resistance and Sales Surveillance 2017. (2019, October 29). GOV.UK. https://www.gov.uk/government/publications/veterinary-antimicrobial-resistance-and-sales-surveillance-2017
• Wright, G. D. (2010). Antibiotic resistance in the environment: A link to the clinic? Current Opinion in Microbiology, 13(5), 589–594. https://doi.org/10.1016/j.mib.2010.08.005
• Xia, J. Q., Yason, C. V., & Kibenge, F. S. (1995). Comparison of dot blot hybridization, polymerase chain reaction, and virus isolation for detection of bovine herpesvirus-1 (BHV-1) in artificially infected bovine semen. Canadian Journal of Veterinary Research = Revue Canadienne De Recherche Veterinaire, 59(2), 102–109.
• Zhu, Y.-G., Johnson, T. A., Su, J.-Q., Qiao, M., Guo, G.-X., Stedtfeld, R. D., Hashsham, S. A., & Tiedje, J. M. (2013). Diverse and abundant antibiotic resistance genes in Chinese swine farms. Proceedings of the National Academy of Sciences of the United States of America, 110(9), 3435–3440. https://doi.org/10.1073/pnas.1222743110
• Prestinaci, F., Pezzotti, P., & Pantosti, A. (2015). Antimicrobial resistance: A global multifaceted phenomenon. Pathogens and Global Health, 109(7), 309–318. https://doi.org/10.1179/2047773215Y.0000000030